Stock & Company Details
Armata Pharmaceuticals Inc $ARMP
Price:
N/A
N/A
37M
$144M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.50
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ARMP technical indicators
Latest Armata Pharmaceuticals Inc (ARMP) indicator readings as of 2026-10-09.
ARMP's 14-day RSI is 39.6, in neutral territory. At $3.63 it is trading 50.0% below its 200-day moving average of $7.25, and below its 50-day average of $4.59. Price sits in the middle of its Bollinger Bands ($2.99 to $4.85). ADX reads 9.6, indicating a range-bound market rather than a trend.
Overview
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. It is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent. Further, the company is committed to advancing phage with drug development expertise that spans bench to clinic including in-house phage specific GMP manufacturing.
Finance Bot
Ask your questions
Start by typing a question below.
